These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8429497)

  • 1. In vitro studies to investigate the reasons for the low potency of cholestyramine and colestipol.
    Benson GM; Haynes C; Blanchard S; Ellis D
    J Pharm Sci; 1993 Jan; 82(1):80-6. PubMed ID: 8429497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric sorbents for bile acids. I: Comparison between cholestyramine and colestipol.
    Zhu XX; Brown GR; St-Pierre LE
    J Pharm Sci; 1992 Jan; 81(1):65-9. PubMed ID: 1619572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SK&F 97426-A: a novel bile acid sequestrant with higher affinities and slower dissociation rates for bile acids in vitro than cholestyramine.
    Benson GM; Alston DR; Hickey DM; Jaxa-Chamiec AA; Whittaker CM; Haynes C; Glen A; Blanchard S; Cresswell SR; Suckling KE
    J Pharm Sci; 1997 Jan; 86(1):76-81. PubMed ID: 9002463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE
    Artery; 1990; 17(5):281-8. PubMed ID: 2396902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cholestyramine on bile acid metabolism in normal man.
    Garbutt JT; Kenney TJ
    J Clin Invest; 1972 Nov; 51(11):2781-9. PubMed ID: 5080408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of antacids and cholestyramine to bind bile acids: effect of pH.
    Mangnall YF; Smythe A; Johnson AG
    Scand J Gastroenterol; 1986 Sep; 21(7):789-94. PubMed ID: 3775246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro binding of lorazepam and lorazepam glucuronide to cholestyramine, colestipol, and activated charcoal.
    Herman RJ; Chaudhary A
    Pharm Res; 1991 Apr; 8(4):538-40. PubMed ID: 1871054
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of an unconventional in vitro drug release test method for a bile acid sequestrant, DMP 504, tablet.
    Wu LS; McCormick TJ; Chang RK; Pang J; McCummings T; Ramos M; Hussain MA
    Pharm Res; 1999 Jul; 16(7):1136-9. PubMed ID: 10450944
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
    Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
    J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of bile acids to cholestyramine at gastric pH conditions.
    Lindenbaum S; Higuchi T
    J Pharm Sci; 1975 Nov; 64(11):1887-9. PubMed ID: 486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism.
    Einarsson K; Ericsson S; Ewerth S; Reihnér E; Rudling M; Ståhlberg D; Angelin B
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S53-8. PubMed ID: 2044645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of bile acids to anion-exchanging drugs in vitro.
    Thale M; Faergeman O
    Scand J Gastroenterol; 1978; 13(3):353-6. PubMed ID: 755279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bile salt-binding resins on the morphology of rat jejunum and colon. A scanning electron microscopy study.
    Cassidy MM; Lightfoot FG; Grau LE; Roy T; Story JA; Kritchevsky D; Vahouny GV
    Dig Dis Sci; 1980 Jul; 25(7):504-12. PubMed ID: 7389538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding properties in vitro of antacids for conjugated bile acids.
    Clain JE; Malagelada JR; Chadwick VS; Hofmann AF
    Gastroenterology; 1977 Sep; 73(3):556-9. PubMed ID: 19335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical model and dimensional analysis of glycocholate binding to cholestyramine resin: implications for in vivo resin performance.
    Polli JE; Amidon GL
    J Pharm Sci; 1995 Dec; 84(12):1446-54. PubMed ID: 8748328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equilibrium and kinetic factors influencing bile sequestrant efficacy.
    Luner PE; Amidon GL
    Pharm Res; 1992 May; 9(5):670-6. PubMed ID: 1608901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the binding of various bile acids and bile salts in vitro by several types of fiber.
    Story JA; Kritchevsky D
    J Nutr; 1976 Sep; 106(9):1292-4. PubMed ID: 956912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of cholestyramine and aluminium hydroxide on the biliary bile acid excretion in rats. An experimental model for the depletion of bile acids in bile.
    Gregus Z; Barth A; Fischer E; Zaumseil J; Klinger W; Varga F
    Acta Biol Med Ger; 1980; 39(6):705-9. PubMed ID: 7456933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential retention of taurine-conjugated bile salts by cholestyramine in the rat ileum.
    Cook DA; Hagerman LM; Schneider DL
    Proc Soc Exp Biol Med; 1972 Jan; 139(1):70-3. PubMed ID: 5007487
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical inquiry. Postcholecystectomy diarrhea: what relieves it?
    Danley T; St Anna L
    J Fam Pract; 2011 Oct; 60(10):632c-d. PubMed ID: 21977493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.